Translational cancer research improves the treatment and support of people affected by cancer through patient-focused research.
A program to connect leading research and clinical centres.
The Cancer Institute NSW is one of the biggest funders of cancer research in the state. In particular, we focus on supporting translational cancer research. Translational cancer research aims to ‘translate’ research findings from the lab into medical practice in a way that has an immediate impact on cancer treatment and in turn outcomes. This is termed ‘from bench to bedside.’
The pages below outline what the Translational Cancer Research Program has contributed to cancer research and collaboration in NSW.
The TCRC program established in 2011 enables more rapid uptake of cancer related research to improve patient care and health systems.
Find out more about each of the Translational Cancer Research Centres and what they contribute to cancer research and collaboration in NSW.
The Cancer Institute NSW has identified five areas key to successfully establishing a Translational Cancer Research Centre.